Table 1 Patient and disease characteristics
From: Long-term functional outcome after laryngeal cancer treatment
Parameter | n (%) |
|---|---|
Total | 477 (100%) |
Male sex | 428 (89.7%) |
Median Age (range) | 64 (36–92) |
Tumor subsite | |
Supraglottic | 124 (26%) |
Glottic | 281 (58.9%) |
Subglottic | 13 (2.7%) |
Transglottic | 59 (12.4%) |
cT stage | |
1a | 185 (38.8%) |
1b | 47 (9.9%) |
2 | 118 (24.7%) |
3 | 79 (16.6%) |
4a | 47 (9.9%) |
4b | 1 (0.2%) |
cN stage | |
0 | 388 (81.3%) |
1 | 24 (5%) |
2a | 4 (0.8%) |
2b | 31 (6.5%) |
2c | 24 (5%) |
3 | 6 (1.3%) |
Clinical UICC stage | |
I | 226 (47.4%) |
II | 97 (20.3%) |
III | 65 (13.6%) |
IVA | 82 (17.2%) |
IVB | 7 (1.5%) |